Profil
Ying Min Wang is currently Director, Digital Health & MedTech at Clavystbio Pte Ltd. since 2022.
Dr. Wang is also Director at Sunbird Bio, Inc. since 2023.
Dr. Wang completed undergraduate studies at Duke University and earned a doctorate from the California Institute of Technology.
Postes actifs de Ying Min Wang
| Sociétés | Poste | Début |
|---|---|---|
Clavystbio Pte Ltd.
Clavystbio Pte Ltd. Investment ManagersFinance Clavystbio invests in companies located across the globe. The firm focuses on biotech, medtech, real estate, service platforms and digital health sectors. It provides financing in early-stage capital requirements. | Private Equity Investor | 01/01/2022 |
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing protein-based technologies to improve diagnosis and treatment of neurological disorders & cancer | Directeur/Membre du Conseil | 01/05/2023 |
Formation de Ying Min Wang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clavystbio Pte Ltd.
Clavystbio Pte Ltd. Investment ManagersFinance Clavystbio invests in companies located across the globe. The firm focuses on biotech, medtech, real estate, service platforms and digital health sectors. It provides financing in early-stage capital requirements. | Finance |
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing protein-based technologies to improve diagnosis and treatment of neurological disorders & cancer | Health Technology |
















